King Faisal Specialist Hospital and Research Centre (KFSHRC) in Madinah has successfully removed a rare benign intramural bladder leiomyoma using a single-port surgical technique. The procedure, completed through a 2cm incision, represents a new application of minimally invasive surgery for this type of tumor. According to the hospital, this marks the first documented use of single-port transvesical surgery to excise an intramural smooth muscle tumor located within the bladder wall.

Key Takeaways

  • KFSHRC Madinah performed single-port bladder surgery through 2cm incision without abdominal opening
  • Procedure removes rare intramural bladder leiomyoma with reduced pain and faster recovery
  • Technique provides direct visualization of deep bladder wall layers during tumor removal
  • Hospital aligns innovation with Saudi Vision 2030 healthcare objectives

How Single-Port Bladder Surgery Works

The single-port transvesical approach enables complete tumor removal by providing direct visualization of the bladder wall’s deep layers. The surgical team performs circumferential dissection around the lesion, manages vascular control, and reconstructs the internal bladder wall following excision.

Traditional treatment for intramural bladder leiomyomas required open abdominal surgery with an external incision into the bladder wall. This conventional method typically resulted in increased post-operative pain, higher blood loss, longer hospitalization periods, and more visible scarring.

Clinical Benefits of Minimally Invasive Approach

The single-port endoscopic technique allows surgeons to access the tumor from inside the bladder while preserving surrounding tissues. According to KFSHRC, the procedure reduces the need for pain medication and lowers the risk of surgical complications.

Additionally, the minimally invasive approach shortens surgery duration and reduces scarring compared to open abdominal procedures. The hospital states this expands treatment options for patients with rare and complex mural tumors.

KFSHRC’s Healthcare Innovation Track Record

KFSHRC reported this achievement supports Saudi Vision 2030’s objectives in medical innovation and clinical excellence. The hospital’s advancement in surgical techniques reflects broader healthcare transformation efforts across the Kingdom.

According to Brand Finance 2025, KFSHRC is the most valuable healthcare brand in Saudi Arabia and the Middle East. The institution is ranked first in the Middle East and Africa region and fifteenth globally among the top 250 academic medical centers for 2025, according to the hospital’s statement.

What’s Next

The hospital has not disclosed whether the single-port transvesical technique will become standard protocol for similar cases. Further clinical data on patient outcomes and recovery metrics would strengthen evidence for broader adoption of this surgical approach for intramural bladder tumors.